Biocodex is a French pharmaceutical company established in 1953, recognized for creating the first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. The company specializes in three key areas: Microbiota care, Women’s health, and Orphan diseases. With a workforce of over 1,700, Biocodex reported net revenues exceeding €500 million in 2023, with a significant international presence. It operates in more than 100 countries, boasting wholly owned subsidiaries in 16 nations and a worldwide distributor network. Biocodex continues to expand its impact on global health through innovative product development.
BIOCODEX
Developing and marketing innovative probiotic solutions for diverse health needs globally.
Open positions at BIOCODEX
0 active listings